The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 09, 2021
Filed:
Sep. 11, 2017
Applicant:
Targovax Oy, Espoo, FI;
Inventors:
Tuuli Ranki, Riihimäki, FI;
Sari Anneli Pesonen, Helsinki, FI;
Magnus Jäderberg, London, GB;
Elina Haavisto, Helsinki, FI;
Lukasz Kuryk, Helsinki, FI;
Antti Vuolanto, Veikkola, FI;
Assignee:
TARGOVAX OY, Espoo, FI;
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2006.01); A61K 39/00 (2006.01); C07K 14/705 (2006.01); A61K 45/06 (2006.01); A61P 35/00 (2006.01); A61K 39/395 (2006.01); A61K 35/761 (2015.01); C07K 14/535 (2006.01);
U.S. Cl.
CPC ...
A61K 39/3955 (2013.01); A61K 35/761 (2013.01); A61P 35/00 (2018.01); C07K 14/535 (2013.01); C07K 16/2818 (2013.01); C07K 16/2827 (2013.01); A61K 2039/505 (2013.01); A61K 2039/545 (2013.01);
Abstract
The invention relates to the combination therapy comprising oncolytic adenovirus vector and a checkpoint inhibitor or checkpoint inhibitors. More specifically, the invention relates to oncolytic adenovirus vector and checkpoint inhibitor or checkpoint inhibitors for use in a cancer therapy.